Early Access — free while we kick the tires
EdgarHawk

venBio Global Strategic Fund III, L.P.

10% Owner

10% Owner
1 filing analyzed · 1 company · Latest 2024-07-22

Companies

Company Buys Sells Direction
Artiva Biotherapeutics, Inc. ARTV 4 0 Net buying

Activity

July 2024
high
Buy
416,666 shares
$4,999,992
Significance 7/10

venBio Strategic Fund III buys 416,666 shares of ARTV for $5.0M (27.4% increase); 4 other insiders bought within 14 days

venBio Global Strategic Fund III, a 10% owner, purchased 416,666 shares at $12.00 on 2024-07-22 for $4,999,992.00, increasing its position by 27.4% to 1,936,637 shares. This purchase occurs in a cluster pattern where 4 other insiders have also bought within the past 14 days. The transaction represents a substantial capital deployment by a major stakeholder in a recently listed company (2 trading days post-IPO). The convergence of multiple insider purchases at a consistent price point suggests coordinated confidence in the early-stage valuation, though investors should note that short trading history limits meaningful trend analysis.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access